LexDanaLexDanabeta
Inventor

Alexander Straub

Inventor
Wuppertal, DE

Overview

73→
Patents
1992–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 73 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds4%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,927,1097-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof202110,519,1547-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof201910,435,403Positive allosteric modulators of muscarinic M2 receptor201910,300,062Bicyclically substituted uracils and the use thereof20199,949,977Bicyclically substituted uracils and the use thereof20189,949,978Bicyclically substituted uracils and the use thereof20189,751,843'Substituted uracils and use thereof'20179,695,131'Substituted uracils as chymase inhibitors'20179,481,672'Bicyclically substituted uracils and the use thereof'20169,150,580'Substituted imidazopyridines and the use thereof'20158,946,215'Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20158,901,311'Method for producing heterocyclic fluoroalkenyl sulfones'20148,822,458'Substituted oxazolidinones and their use in the field of blood coagulation'20148,778,964'Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use'20148,530,505'Substituted oxazolidinones and their use in the field of blood coagulation'20138,129,378'Substituted oxazolidinones and their use in the field of blood coagulation'20128,124,786'Mental-catalyzed process for preparation of substituted pyrazolecarboxamides'20128,071,824'Method for producing alkenylnitrobenzene derivatives unbranched in the 1′-position'20118,053,572'Alkyl-analide producing method'20117,977,494'Method for producing substituted pyrazolecarboxylic acid chlorides'20117,767,702'Substituted oxazolidinones for combinational therapy'20107,598,378'Method for the production of 4-(4-aminophenyl)-3-morpholinone'20097,592,339'Substituted oxazolidinones and their use in the field of blood coagulation'20097,585,860'Substituted oxazolidinones and their use in the field of blood coagulation'20097,582,666'Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics'20097,576,111'Substituted oxazolidinones and their use in the field of blood coagulation'20097,482,472'Substituted isoindoles and their use'20097,439,408'Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles'20087,385,093'Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles'20087,317,016'Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives'20087,291,622'Medical uses of carbamate-substituted pyrazolo-pyridine derivatives'20077,189,738'Substituted isoindoles and their use thereof'20077,157,456'Substituted oxazolidinones and their use in the field of blood coagulation'20077,115,599'Sulfonamide-substituted pyrazolopyridine compounds'20067,078,527'Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles'20067,034,017'Substituted oxazolidinones and their use in the field of blood coagulation'20066,933,295'Substituted isoindoles and the use thereof'20056,919,345'Sulfonate substituted pyrazol pyridine derivatives'20056,903,089'Lactam-substituted pyrazolopyridine derivatives'20056,833,364'Substituted pyrazole derivatives'20046,743,798'Substituted pyrazole derivatives condensed with six-membered heterocyclic rings'20046,693,102'Pyridine-substituted pyrazolopyridine derivatives'20046,462,068'Heterocyclylmethyl-substituted pyrazole derivatives'20026,451,805'Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases'20026,414,009'Heterocyclylmethyl-substituted pyrazol derivatives'20026,410,740'Heterocyclylmethyl-substituted pyrazol derivatives'20026,387,940'Heterocyclylmethyl-substituted pyrazole derivatives'20026,180,656'Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems'20016,166,027'Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases'20005,721,248'4-bicyclically substituted dihydropyridines, and their use in medicaments'19985,708,177'Process for the preparation of optically active ortho-substituted 4-aryl-dihydropyridines'19985,629,320'3-quinolyl-substituted dihydropyridines, and their use in medicaments'19975,550,245'3-quinolyl-substituted dihydropyridines, processes for their preparation and their use in medicaments'19965,545,646'4-bicyclically substituted dihydropyridines and their use in medicaments'19965,514,803'2,6-disubstituted 4-quinolyl-dihydropyridines'19965,508,406'Quinolyl-dihydropyridine esters, processes for their preparation, and their use in medicaments'19965,504,209'2-amino-5-cyano-4-quinolydihydropyridine esters, processes for their preparation and their use in medicaments'19965,504,210'3-quinolyl-substituted dihydropyridines and their use in medicaments'19965,502,062'2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use'19965,478,937'Certain cinnoline carboxaldehydes and naphthyridine carboxaldehydes useful as intermediates'19955,436,342'Condensed quinolyl-dihydropyridines, processes for their preparation and their use in medicaments'19955,434,153'2-amino-4-heteroaryl-1,4-dihydropyridines and their use in medicaments'19955,432,282'Process for preparing 1,4-dihydro-2-amino-3-carboxy-5-cyano-pyridine derivatives'19955,412,099'Intermediate benzothiazolyl- and benzoxazolyl-aldehyde compounds'19955,410,055'3-phenyl-1,7-naphthyridine and cinnoline-5-carboxyaldehyde intermediates for medicaments'19955,380,851'2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation'19955,364,855'4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their preparation and their use in medicaments'19945,262,429'Aryl-quinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid compounds which have useful pharmaceutical utility'19935,254,692'2,6-dialkyl-4-(benzothiazol- or benzoxazol-7-yl)-1,4-dihydropyridines'19935,225,558'2-amino-5-cyano-1,4-dihydropyridines, and their use in medicaments'19935,204,472'Quinoline and isoquinoline intermediates'19935,200,420'2,6-dialkyl-4-(benzothiazol- or benzoxazol-4-yl-1,4-dihydropyridines'19935,100,900'Positive inotropically active 4-quinolyl-dihydropyridines and use thereas'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2021Patents assigned to BAYER AG (41)· patent assignee history
1992–2021Based in Wuppertal, DE· patent location history
2006–2012Patents assigned to BAYER CROPSCIENCE AG (6)· patent assignee history
2009–2010Patents assigned to BAYER SCHERING PHARMA AG (6)· patent assignee history
2011–2015Patents assigned to STRAUB ALEXANDER (6)· patent assignee history
2012–2021Patents assigned to Bayer Pharma AG (13)· patent assignee history
2014Based in Leverkusen, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER AG411992–2021
Bayer Pharma AG132012–2021
BAYER CROPSCIENCE AG62006–2012
BAYER SCHERING PHARMA AG62009–2010
STRAUB ALEXANDERself62011–2015
Locations
LocationPatentsSpan
Wuppertal, DE721992–2021
Leverkusen, DE12014